FAST Spain Awards First Research Grant
FAST Spain awards its first research grant to study two novel biomarkers—the endocannabinoid system and transcriptomic profile—to better track Angelman syndrome progression and treatment.
FAST Spain awards its first research grant to study two novel biomarkers—the endocannabinoid system and transcriptomic profile—to better track Angelman syndrome progression and treatment.
Find information on Angelman syndrome, research, clinical trials, resources, and ways to get involved.